ArticleCancers2023

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study).

Joshua D Rosenblat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.